IN201641043301A - - Google Patents

Info

Publication number
IN201641043301A
IN201641043301A IN201641043301A IN201641043301A IN201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A
Authority
IN
India
Application number
IN201641043301A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN201641043301A priority Critical patent/IN201641043301A/en
Publication of IN201641043301A publication Critical patent/IN201641043301A/en

Links

IN201641043301A 2016-12-19 2016-12-19 IN201641043301A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN201641043301A IN201641043301A (en) 2016-12-19 2016-12-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201641043301A IN201641043301A (en) 2016-12-19 2016-12-19

Publications (1)

Publication Number Publication Date
IN201641043301A true IN201641043301A (en) 2018-06-22

Family

ID=75714404

Family Applications (1)

Application Number Title Priority Date Filing Date
IN201641043301A IN201641043301A (en) 2016-12-19 2016-12-19

Country Status (1)

Country Link
IN (1) IN201641043301A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111205224A (en) * 2020-04-22 2020-05-29 南京佰麦生物技术有限公司 Crystal form of roxasistat hydrate, and preparation method and application thereof
WO2021077994A1 (en) 2019-10-22 2021-04-29 苏州科睿思制药有限公司 Crystal form of hypoxia-inducible factor-prolyl hydroxylase inhibitor
CN113956200A (en) * 2021-12-16 2022-01-21 南京威凯尔生物医药科技有限公司 Crystallization process of roxasistat bulk drug with controlled particle size

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021077994A1 (en) 2019-10-22 2021-04-29 苏州科睿思制药有限公司 Crystal form of hypoxia-inducible factor-prolyl hydroxylase inhibitor
CN111205224A (en) * 2020-04-22 2020-05-29 南京佰麦生物技术有限公司 Crystal form of roxasistat hydrate, and preparation method and application thereof
CN113956200A (en) * 2021-12-16 2022-01-21 南京威凯尔生物医药科技有限公司 Crystallization process of roxasistat bulk drug with controlled particle size

Similar Documents

Publication Publication Date Title
RU2019102674A3 (en)
IN201641043301A (en)
JP1572097S (en)
CN303604000S (en)
CN303554014S (en)
CN303559934S (en)
CN303553036S (en)
CN303542903S (en)
CN303541635S (en)
CN303540703S (en)
CN303540162S (en)
CN303568087S (en)
CN303569857S (en)
CN303574178S (en)
CN303622554S (en)
CN303618485S (en)
CN303617981S (en)
CN303612396S (en)
CN303611825S (en)
CN303610220S (en)
CN303607976S (en)
CN303607189S (en)
CN303606875S (en)
CN303573621S (en)
CN303622761S (en)